BPI West 2022

March 14-17, 2022, San Diego, CA/ Online

Join Alira Health at BioProcess International US West to learn how to improve process efficiencies and maintain product quality across all phases of bioprocessing.

Our speaker, Bill Perry, Consultant at Alira Health, will be giving a presentation ‘From Gene to IND – Selecting a CDMO Tailored to mAbs or More Complex Biomolecules’. 

About the presentation:

For many biotech start-ups hoping to introduce new biotherapeutics, financing realities and other considerations require that they outsource to CDMOs the development, scale-up and manufacture of lead biomolecules that are to be tested clinically. Selecting and managing CDMOs for cell line and process development as well as manufacturing can be a daunting task. There are different commercially available cell lines and GMP manufacturers to evaluate, and it is critical to find the right partner who can achieve the sponsor’s target product profile on time and on budget. In this talk, I will present case studies in which I will explain the decision-making process that we use to help sponsors select CDMOs for either mAbs or more complex molecules. In addition, key considerations to manage CDMOs effectively will be discussed.

Learn More about CDMOs

For more on selecting a CDMO, check out our Best Practices in Selecting a CDMO series.

Events
Category:
Published on:
February 2, 2022
Our Speaker
Bill Perry, Alira Health

Bill Perry

Consultant Bill is a bioprocess engineering technical leader with 17 years of experience in the industry. Over this time, he has supported multiple products at various stages of development, from pre-clinical, clinical development and manufacturing, through process validation and commercialization. He has supported biologic products, including monoclonal antibody therapeutics at Amgen and microbial fermentation therapeutics at Merck & Co. and KBI. Bill has also supported synthetic oligonucleotide products at Ophthotech and miRagen. Bill holds Bachelor’s Degrees from the University of Colorado as well as a Master’s Degree in Chemical Engineering Practice and a Ph.D. in Chemical Engineering from the Massachusetts Institute of Technology.
Our Delegate
Steven Chamow

Steven Chamow

Senior Vice President, CMC Development

Related news

Publications July 11, 2023
Five Years Evolution of Chemotherapy Administration in Home Care in France
Have a look at the poster to get an overview of the dynamics in the development of chemotherapy in home care across different French regions during a five-year period.
Clinical France Outcomes Research
Events June 20, 2023
Advanced Wound Care Summit
We are pleased to announce that we will sponsor, attend, and speak at Advanced Wound Care Summit.
Clinical Clinical Trials Wound Healing
Events February 2, 2023
ACDM 2023
We are pleased to announce that we will be sponsoring and attending ACDM 2023. ACDM23 offers a full two-day program of expert speakers, specialist panels, workshops and debates which(...)
Clinical Data Science
Blog December 21, 2022
2022 Recap: Your Favorite Alira Health Publications
In 2022, the Alira Health team of scientists, strategists, economists, clinicians, and biostatisticians shared actionable insights, industry thought leadership, and leading-edge guidance(...)
Clinical Digital Health Market Access MedTech Pharma Regulatory
Blog December 14, 2022
How to Optimize Clinical Research with Patient Advisory Boards
Patient engagement is increasingly essential to all stages of product development—particularly clinical research.
Clinical Patient Advocacy Patient Centricity Patient Engagement
Events November 30, 2022
Innovations in Wound Healing
We are excited to attend and sponsor a poster presentation at the Innovations in Wound Healing event this year. This unique meeting is led by a group of experienced educators, scientists(...)
Clinical Patient Centricity Wound Healing
Scientific Articles September 16, 2022
Analyzing and Interpreting Data from Biometric Monitoring Technologies in Clinical Trials
The rise of technology in clinical research allows us to capture meaningful aspects of health in clinical study participants.
Biometrics Clinical eCOA
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.